您的位置: 首页 > 农业专利 > 详情页

RECOMBINANT beta2-GPI PEPTIDES AND THE USE THEREOF IN ANTI-TUMOR THERAPY
专利权人:
发明人:
Anna CHIANG,Shr-Jeng LEU
申请号:
US15270630
公开号:
US20180085454A1
申请日:
2016.09.20
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A purified recombinant β2-GPI peptide having at least one tumor inhibitory β2-GPI domain, and the use thereof in anti-tumor therapy. Producing and purifying various recombinant β2-GPI fragments using a viral expression system screening functional domains of β2-GPI with potential in inhibiting tumor cell proliferation and migration preparing purified recombinant β2-GPI peptides having the functional domains including β2-GPI-D1, β2-GPI-D4, β2-GPI-D5, β2-GPI-D1234, β2-GPI-D12345 and β2-GPI-D2345 and applying the purified recombinant β2-GPI peptides in the development of anti-tumor protein drugs or related therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充